Skip to main content
Markets · Live
DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%Nvidia—▼ TSMC—▼ Alphabet—▼ Bitcoin—▼ DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%Nvidia—▼ TSMC—▼ Alphabet—▼ Bitcoin—▼
New York--:--
Chicago--:--
Denver--:--
Los Angeles--:--
Honolulu--:--
Anchorage--:--
Tokyo--:--
Berlin--:--
London--:--
UTC--:--

Breaking

BLOOMBERG MARKETS — Dimon Concerned Inflation May Be Sticky, Rates Go Up · Oct 6, 10:07 AM ET
STAT

STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more

The FDA is opening applications for a pilot program designed to shorten the time it takes for drugmakers to begin testing their products in humans

Ed Silverman
By Ed Silverman· STAT News· Published · Photo: Alex Hogan/STAT

Rights: fair use excerpt

STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
Reporting by Ed SilvermanSource: STAT NewsPhoto: Alex Hogan/STATUpdated October 6, 2026
PHOTO: ALEX HOGAN/STAT

---

Ed Silverman · STAT News · Photo: Alex Hogan/STAT

Source & Credit

Reporting and photography credited as noted above. Originally published by STAT News.

Members only

Checking your membership…